CONSTELLATION BRANDS INC-A (CB1A.DE) Fundamental Analysis & Valuation

FRA:CB1A • US21036P1084

Current stock price

143 EUR
+6.5 (+4.76%)
Last:

This CB1A.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CB1A.DE Profitability Analysis

1.1 Basic Checks

  • CB1A had positive earnings in the past year.
  • In the past year CB1A had a positive cash flow from operations.
  • In the past 5 years CB1A reported 4 times negative net income.
  • CB1A had a positive operating cash flow in 4 of the past 5 years.
CB1A.DE Yearly Net Income VS EBIT VS OCF VS FCFCB1A.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.12%, CB1A belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
  • CB1A has a Return On Equity of 14.39%. This is in the better half of the industry: CB1A outperforms 77.78% of its industry peers.
  • CB1A's Return On Invested Capital of 12.66% is amongst the best of the industry. CB1A outperforms 88.89% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CB1A is above the industry average of 7.49%.
  • The last Return On Invested Capital (12.66%) for CB1A is above the 3 year average (12.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.12%
ROE 14.39%
ROIC 12.66%
ROA(3y)2.02%
ROA(5y)2.65%
ROE(3y)5.23%
ROE(5y)6.01%
ROIC(3y)12.24%
ROIC(5y)11.12%
CB1A.DE Yearly ROA, ROE, ROICCB1A.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

  • The Profit Margin of CB1A (11.83%) is better than 77.78% of its industry peers.
  • CB1A has a better Operating Margin (33.76%) than 100.00% of its industry peers.
  • CB1A's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 52.60%, CB1A perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • CB1A's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.76%
PM (TTM) 11.83%
GM 52.6%
OM growth 3Y0.41%
OM growth 5Y2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.64%
GM growth 5Y0.98%
CB1A.DE Yearly Profit, Operating, Gross MarginsCB1A.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

5

2. CB1A.DE Health Analysis

2.1 Basic Checks

  • CB1A has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CB1A has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CB1A.DE Yearly Shares OutstandingCB1A.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CB1A.DE Yearly Total Debt VS Total AssetsCB1A.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • CB1A has an Altman-Z score of 3.08. This indicates that CB1A is financially healthy and has little risk of bankruptcy at the moment.
  • CB1A's Altman-Z score of 3.08 is amongst the best of the industry. CB1A outperforms 81.48% of its industry peers.
  • The Debt to FCF ratio of CB1A is 6.05, which is on the high side as it means it would take CB1A, 6.05 years of fcf income to pay off all of its debts.
  • CB1A's Debt to FCF ratio of 6.05 is amongst the best of the industry. CB1A outperforms 85.19% of its industry peers.
  • CB1A has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
  • CB1A's Debt to Equity ratio of 1.38 is on the low side compared to the rest of the industry. CB1A is outperformed by 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 6.05
Altman-Z 3.08
ROIC/WACC1.81
WACC6.99%
CB1A.DE Yearly LT Debt VS Equity VS FCFCB1A.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • CB1A has a Current Ratio of 1.34. This is a normal value and indicates that CB1A is financially healthy and should not expect problems in meeting its short term obligations.
  • CB1A has a Current ratio (1.34) which is in line with its industry peers.
  • A Quick Ratio of 0.70 indicates that CB1A may have some problems paying its short term obligations.
  • CB1A has a Quick ratio of 0.70. This is comparable to the rest of the industry: CB1A outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 0.7
CB1A.DE Yearly Current Assets VS Current LiabilitesCB1A.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2

3. CB1A.DE Growth Analysis

3.1 Past

  • CB1A shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.23%.
  • CB1A shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.45% yearly.
EPS 1Y (TTM)-14.23%
EPS 3Y3.54%
EPS 5Y3.45%
EPS Q2Q%-27.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.27%

3.2 Future

  • CB1A is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.87% yearly.
  • Based on estimates for the next years, CB1A will show a small growth in Revenue. The Revenue will grow by 2.74% on average per year.
EPS Next Y5.67%
EPS Next 2Y5.23%
EPS Next 3Y6.38%
EPS Next 5Y4.87%
Revenue Next Year0.48%
Revenue Next 2Y1.36%
Revenue Next 3Y2.41%
Revenue Next 5Y2.74%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CB1A.DE Yearly Revenue VS EstimatesCB1A.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
CB1A.DE Yearly EPS VS EstimatesCB1A.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

4

4. CB1A.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • CB1A is valuated correctly with a Price/Earnings ratio of 14.19.
  • Compared to the rest of the industry, the Price/Earnings ratio of CB1A indicates a somewhat cheap valuation: CB1A is cheaper than 74.07% of the companies listed in the same industry.
  • CB1A's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.86.
  • A Price/Forward Earnings ratio of 13.42 indicates a correct valuation of CB1A.
  • Based on the Price/Forward Earnings ratio, CB1A is valued a bit cheaper than the industry average as 62.96% of the companies are valued more expensively.
  • CB1A is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.19
Fwd PE 13.42
CB1A.DE Price Earnings VS Forward Price EarningsCB1A.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CB1A is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CB1A is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 16.48
EV/EBITDA 10.94
CB1A.DE Per share dataCB1A.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CB1A does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of CB1A may justify a higher PE ratio.
PEG (NY)2.5
PEG (5Y)4.12
EPS Next 2Y5.23%
EPS Next 3Y6.38%

4

5. CB1A.DE Dividend Analysis

5.1 Amount

  • CB1A has a Yearly Dividend Yield of 2.53%. Purely for dividend investing, there may be better candidates out there.
  • CB1A's Dividend Yield is comparable with the industry average which is at 2.76.
  • Compared to an average S&P500 Dividend Yield of 1.82, CB1A pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.53%

5.2 History

  • On average, the dividend of CB1A grows each year by 6.29%, which is quite nice.
Dividend Growth(5Y)6.29%
Div Incr Years0
Div Non Decr Years1
CB1A.DE Yearly Dividends per shareCB1A.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2025 2026 1 2 3

5.3 Sustainability

  • CB1A pays out 64.83% of its income as dividend. This is not a sustainable payout ratio.
  • CB1A's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP64.83%
EPS Next 2Y5.23%
EPS Next 3Y6.38%
CB1A.DE Yearly Income VS Free CF VS DividendCB1A.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B
CB1A.DE Dividend Payout.CB1A.DE Dividend Payout, showing the Payout Ratio.CB1A.DE Dividend Payout.PayoutRetained Earnings

CB1A.DE Fundamentals: All Metrics, Ratios and Statistics

CONSTELLATION BRANDS INC-A

FRA:CB1A (4/10/2026, 7:00:00 PM)

143

+6.5 (+4.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)04-08
Earnings (Next)06-29
Inst Owners80.27%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap24.80B
Revenue(TTM)N/A
Net Income(TTM)1.11B
Analysts72.86
Price Target152.77 (6.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.53%
Yearly Dividend3.46
Dividend Growth(5Y)6.29%
DP64.83%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.62%
Min EPS beat(2)6.26%
Max EPS beat(2)14.99%
EPS beat(4)3
Avg EPS beat(4)8%
Min EPS beat(4)-3.57%
Max EPS beat(4)14.99%
EPS beat(8)6
Avg EPS beat(8)5.42%
EPS beat(12)10
Avg EPS beat(12)5.61%
EPS beat(16)13
Avg EPS beat(16)5.76%
Revenue beat(2)1
Avg Revenue beat(2)0.9%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.92%
Revenue beat(4)2
Avg Revenue beat(4)-0.02%
Min Revenue beat(4)-2.48%
Max Revenue beat(4)1.92%
Revenue beat(8)3
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.82%
Revenue beat(16)8
Avg Revenue beat(16)0.45%
PT rev (1m)-0.78%
PT rev (3m)0.57%
EPS NQ rev (1m)1.52%
EPS NQ rev (3m)-13.68%
EPS NY rev (1m)0.04%
EPS NY rev (3m)1.21%
Revenue NQ rev (1m)1.28%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 14.19
Fwd PE 13.42
P/S 3.1
P/FCF 16.48
P/OCF 10.75
P/B 3.77
P/tB N/A
EV/EBITDA 10.94
EPS(TTM)10.08
EY7.05%
EPS(NY)10.66
Fwd EY7.45%
FCF(TTM)8.68
FCFY6.07%
OCF(TTM)13.3
OCFY9.3%
SpS46.2
BVpS37.97
TBVpS-0.06
PEG (NY)2.5
PEG (5Y)4.12
Graham Number92.8
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 14.39%
ROCE 16.24%
ROIC 12.66%
ROICexc 12.76%
ROICexgc 20.96%
OM 33.76%
PM (TTM) 11.83%
GM 52.6%
FCFM 18.78%
ROA(3y)2.02%
ROA(5y)2.65%
ROE(3y)5.23%
ROE(5y)6.01%
ROIC(3y)12.24%
ROIC(5y)11.12%
ROICexc(3y)12.3%
ROICexc(5y)11.2%
ROICexgc(3y)22.37%
ROICexgc(5y)20.22%
ROCE(3y)15.97%
ROCE(5y)14.37%
ROICexgc growth 3Y11.53%
ROICexgc growth 5Y13.24%
ROICexc growth 3Y14.12%
ROICexc growth 5Y13.2%
OM growth 3Y0.41%
OM growth 5Y2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.64%
GM growth 5Y0.98%
F-Score7
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 6.05
Debt/EBITDA 2.98
Cap/Depr 227.4%
Cap/Sales 10%
Interest Coverage 250
Cash Conversion 75.43%
Profit Quality 158.81%
Current Ratio 1.34
Quick Ratio 0.7
Altman-Z 3.08
F-Score7
WACC6.99%
ROIC/WACC1.81
Cap/Depr(3y)275.65%
Cap/Depr(5y)283.18%
Cap/Sales(3y)11.86%
Cap/Sales(5y)11.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.23%
EPS 3Y3.54%
EPS 5Y3.45%
EPS Q2Q%-27.76%
EPS Next Y5.67%
EPS Next 2Y5.23%
EPS Next 3Y6.38%
EPS Next 5Y4.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.27%
Revenue Next Year0.48%
Revenue Next 2Y1.36%
Revenue Next 3Y2.41%
Revenue Next 5Y2.74%
EBIT growth 1Y-9.11%
EBIT growth 3Y5.43%
EBIT growth 5Y6.27%
EBIT Next Year-2.72%
EBIT Next 3Y1.84%
EBIT Next 5Y1.72%
FCF growth 1Y12.99%
FCF growth 3Y4.91%
FCF growth 5Y1.21%
OCF growth 1Y-4.33%
OCF growth 3Y5.23%
OCF growth 5Y4.32%

CONSTELLATION BRANDS INC-A / CB1A.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CONSTELLATION BRANDS INC-A (CB1A.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CB1A.DE.


What is the valuation status of CONSTELLATION BRANDS INC-A (CB1A.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to CONSTELLATION BRANDS INC-A (CB1A.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for CONSTELLATION BRANDS INC-A?

CONSTELLATION BRANDS INC-A (CB1A.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for CB1A stock?

The Price/Earnings (PE) ratio for CONSTELLATION BRANDS INC-A (CB1A.DE) is 14.19 and the Price/Book (PB) ratio is 3.77.


Can you provide the dividend sustainability for CB1A stock?

The dividend rating of CONSTELLATION BRANDS INC-A (CB1A.DE) is 4 / 10 and the dividend payout ratio is 64.83%.